Contact
searchSearch
HMP Global

Volume 2 - Issue 1 - March 2022

Original Contribution
The Vital Role of Plastic Surgeons in Multidisciplinary Care for Wound Healing After Endovascular Revascularization in Patients With Chronic Limb-Threatening Ischemia in Japan
03/21/2022
Masahiko Fujihara, MD; Mitsuyoshi Takahara, MD, PhD; Osamu Iida, MD; Yoshimitsu Soga, MD, PhD; Terutoshi Yamaoka, MD, PhD; Makoto Utsunomiya, MD; Yoshiaki Yokoi, MD
Our study aim was to investigate the complete wound-healing rate in patients with chronic limb-threatening ischemia after endovascular revascularization, comparing the effectiveness of wound care management by plastic surgeons with other...
Our study aim was to investigate the complete wound-healing rate in patients with chronic limb-threatening ischemia after endovascular revascularization, comparing the effectiveness of wound care management by plastic surgeons with other...
Our study aim was to investigate...
03/21/2022
Journal of Critical Limb Ischemia
Editorial/Commentary
Do We Still Need Plastic Surgery on the Limb-Preservation Team? Yes, If You Can Find Them
03/21/2022
Earl M. Johnson, Jr., MD, FACS
Board Certified Plastic Surgeon Earl M. Johnson, Jr, comments on a study by Fujihara et al, who evaluate the current impact of plastic surgeons in managing wounds for patients with CLTI.
Board Certified Plastic Surgeon Earl M. Johnson, Jr, comments on a study by Fujihara et al, who evaluate the current impact of plastic surgeons in managing wounds for patients with CLTI.
Board Certified Plastic Surgeon...
03/21/2022
Journal of Critical Limb Ischemia
Original Contribution
Drug-Coated Versus Uncoated Percutaneous Transluminal Angioplasty Balloons for the Treatment of Infrapopliteal Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
03/21/2022
Shadi Al Halabi, MD, MPH; Erin Templeton; Carmen Heaney, BSN; Fadi Saab, MD, FACC, FSCAI; Ramon L. Varcoe, MBBS, MS, PhD; Jos C. van den Berg, MD, PhD; Jaafer A. Golzar, MD; Nouri Al-Khaled, MD; Ehrin J. Armstrong, MD, MSc, FACC; Jihad A. Mustapha, MD, FACC, FSCAI
We performed a meta-analysis of randomized controlled trials investigating the clinical outcomes of patients undergoing percutaneous revascularization with DCB vs percutaneous transluminal angioplasty (PTA) of infrapopliteal arteries.
We performed a meta-analysis of randomized controlled trials investigating the clinical outcomes of patients undergoing percutaneous revascularization with DCB vs percutaneous transluminal angioplasty (PTA) of infrapopliteal arteries.
We performed a meta-analysis of...
03/21/2022
Journal of Critical Limb Ischemia
Editorial/Commentary
Systematic Meta-analysis—A Scientific Gold Standard for All Therapies?
03/21/2022
Thomas Zeller, MD, PhD
Dr Zeller comments on a recent JCLI meta-analysis by Al Halabi et al, who examined paclitaxel-coated drug-coated balloon (DCB) angioplasty in infrapopliteal artery lesions and found significant benefits for the use of DCB.
Dr Zeller comments on a recent JCLI meta-analysis by Al Halabi et al, who examined paclitaxel-coated drug-coated balloon (DCB) angioplasty in infrapopliteal artery lesions and found significant benefits for the use of DCB.
Dr Zeller comments on a recent...
03/21/2022
Journal of Critical Limb Ischemia
Original Contribution
Cost-Effectiveness of Endovascular Intervention Versus Bypass Surgery in Patients With Chronic Limb-Threatening Ischemia and Principal Target Lesion in the Femoropopliteal Segment
03/21/2022
Angelica Perlander, MD; Joakim Nordanstig, MD, PhD; Klas Österberg, MD, PhD; Michael Svensson, PhD
This study investigates the cost-effectiveness of bypass surgery vs endovascular intervention in CLTI with femoropopliteal lesions.
This study investigates the cost-effectiveness of bypass surgery vs endovascular intervention in CLTI with femoropopliteal lesions.
This study investigates the...
03/21/2022
Journal of Critical Limb Ischemia
Editorial/Commentary
Cost-Effectiveness of Critical Limb Ischemia Treatments—Critical Gaps Remain
03/21/2022
Ido Weinberg, MD; Michael R. Jaff, MD, DO
The recently published JCLI study by Perlander and colleagues offers an opportunity to focus on the existing gaps in our understanding of cost-effectiveness in the care for CLTI patients.
The recently published JCLI study by Perlander and colleagues offers an opportunity to focus on the existing gaps in our understanding of cost-effectiveness in the care for CLTI patients.
The recently published JCLI...
03/21/2022
Journal of Critical Limb Ischemia

News

News
Microbot Medical Receives FDA 510(k) Clearance for Its Liberty Endovascular Robotic System
09/08/2025
The FDA has granted 510(k) clearance for the LIBERTY® System, the first FDA cleared single-use, remotely operated robotic system for peripheral endovascular procedures.
The FDA has granted 510(k) clearance for the LIBERTY® System, the first FDA cleared single-use, remotely operated robotic system for peripheral endovascular procedures.
The FDA has granted 510(k)...
09/08/2025
Journal of Critical Limb Ischemia
Dr van den Berg
AMP 2025
Jos van den Berg, MD, PhD, Highlights the Growing Economic Burden of CLTI in Europe
08/14/2025
Jos C. van den Berg, MD, PhD
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
At AMP 2025, Interventional radiologist Jos van den Berg, MD, PhD, from the Clinica Luganese Moncucco in Lugano, Switzerland, delivered a presentation titled “The Economic Burden of CLTI in Europe.”
At AMP 2025, Interventional...
08/14/2025
Journal of Critical Limb Ischemia
DR NEVILLE
AMP 2025
Evolving Metrics: Dr Richard Neville Explains How Quality Assessment in CLTI Care Is Being Re-Engineered
08/14/2025
Richard Neville, MD
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines how CLTI programs are redefining “quality.” The era of anecdotal morbidity and mortality reviews has given way to continuous, data-driven evaluation aligned with value-based care.
Richard Neville, MD, outlines...
08/14/2025
Journal of Critical Limb Ischemia
AMBITION BTK TRIAL FOR CLTI
AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia
07/24/2025
AMBITION BTK is a prospective, multicenter, randomized controlled trial (RCT) designed to investigate the clinical safety and effectiveness of the Auryon Atherectomy System combined with standard balloon angioplasty, compared to balloon...
AMBITION BTK is a prospective, multicenter, randomized controlled trial (RCT) designed to investigate the clinical safety and effectiveness of the Auryon Atherectomy System combined with standard balloon angioplasty, compared to balloon...
AMBITION BTK is a prospective,...
07/24/2025
Vascular Disease Management

Stay in the Know

Journal of Critical Limb Ischemia Newsletter

March 2022 Volume 2 Issue 1

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use